This study is testing the investigational drug VTP-1000 for the potential treatment of celiac disease. Participants must be ages 18–65, biopsy-diagnosed with celiac disease, and on a gluten-free diet for 12 months (other criteria apply). Learn more at
avalon.celiac.org